^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    papaverine

    Associations
    News
    Trials
    Company:
    Generic mfg.
    Drug class:
    Ca2+ channel antagonist, Mitochondria complex 1 inhibitor, PDE inhibitor, Vasodilator agent
    Related drugs:
    Associations
    News
    Trials